US3622458A - Production of a new protease - Google Patents
Production of a new protease Download PDFInfo
- Publication number
- US3622458A US3622458A US861911A US3622458DA US3622458A US 3622458 A US3622458 A US 3622458A US 861911 A US861911 A US 861911A US 3622458D A US3622458D A US 3622458DA US 3622458 A US3622458 A US 3622458A
- Authority
- US
- United States
- Prior art keywords
- enzyme
- percent
- production
- alkaline protease
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108091005804 Peptidases Proteins 0.000 title claims abstract description 30
- 239000004365 Protease Substances 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title claims description 24
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title claims 2
- 102000004190 Enzymes Human genes 0.000 claims abstract description 146
- 108090000790 Enzymes Proteins 0.000 claims abstract description 146
- 238000000034 method Methods 0.000 claims abstract description 59
- 239000013078 crystal Substances 0.000 claims abstract description 30
- 108091005658 Basic proteases Proteins 0.000 claims abstract description 28
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 11
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 10
- 230000008569 process Effects 0.000 claims description 29
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 22
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 22
- 239000000243 solution Substances 0.000 claims description 21
- 239000000706 filtrate Substances 0.000 claims description 20
- 235000002639 sodium chloride Nutrition 0.000 claims description 20
- 239000002244 precipitate Substances 0.000 claims description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000000872 buffer Substances 0.000 claims description 14
- 239000012153 distilled water Substances 0.000 claims description 14
- 239000008103 glucose Substances 0.000 claims description 14
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 13
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 13
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- 239000007853 buffer solution Substances 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 235000013372 meat Nutrition 0.000 claims description 11
- 238000001556 precipitation Methods 0.000 claims description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 230000001376 precipitating effect Effects 0.000 claims description 10
- 239000006188 syrup Substances 0.000 claims description 10
- 235000020357 syrup Nutrition 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 238000000746 purification Methods 0.000 claims description 9
- 239000008107 starch Substances 0.000 claims description 9
- 235000019698 starch Nutrition 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 8
- 229920005654 Sephadex Polymers 0.000 claims description 7
- 239000012507 Sephadex™ Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 235000019733 Fish meal Nutrition 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 239000004467 fishmeal Substances 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 4
- 239000003456 ion exchange resin Substances 0.000 claims description 4
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 4
- 235000012054 meals Nutrition 0.000 claims description 4
- 229960004793 sucrose Drugs 0.000 claims description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 3
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 3
- 235000013379 molasses Nutrition 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 238000005185 salting out Methods 0.000 claims description 3
- 239000004254 Ammonium phosphate Substances 0.000 claims description 2
- 229920000742 Cotton Polymers 0.000 claims description 2
- 229910000148 ammonium phosphate Inorganic materials 0.000 claims description 2
- 235000019289 ammonium phosphates Nutrition 0.000 claims description 2
- 235000013877 carbamide Nutrition 0.000 claims description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 claims description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims 1
- 235000019797 dipotassium phosphate Nutrition 0.000 claims 1
- 102000035195 Peptidases Human genes 0.000 abstract description 28
- 239000000758 substrate Substances 0.000 abstract description 26
- 230000002255 enzymatic effect Effects 0.000 abstract description 17
- 150000001413 amino acids Chemical class 0.000 abstract description 16
- 239000000203 mixture Substances 0.000 abstract description 14
- 238000004458 analytical method Methods 0.000 abstract description 5
- 239000013065 commercial product Substances 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000000354 decomposition reaction Methods 0.000 abstract description 2
- 229940088598 enzyme Drugs 0.000 description 133
- 230000000694 effects Effects 0.000 description 54
- 239000002609 medium Substances 0.000 description 18
- 229940024606 amino acid Drugs 0.000 description 16
- 235000001014 amino acid Nutrition 0.000 description 16
- 239000005018 casein Substances 0.000 description 10
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 10
- 235000021240 caseins Nutrition 0.000 description 10
- 239000006916 nutrient agar Substances 0.000 description 10
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 9
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 8
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 7
- 229960001153 serine Drugs 0.000 description 7
- 235000004400 serine Nutrition 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical group NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 229960003767 alanine Drugs 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000004062 sedimentation Methods 0.000 description 6
- 238000011218 seed culture Methods 0.000 description 6
- 229960004441 tyrosine Drugs 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical group CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 5
- 239000004472 Lysine Chemical group 0.000 description 5
- 108010056079 Subtilisins Proteins 0.000 description 5
- 102000005158 Subtilisins Human genes 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 239000010200 folin Substances 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 229960003136 leucine Drugs 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 4
- 229960002885 histidine Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000002797 proteolythic effect Effects 0.000 description 4
- 229960004295 valine Drugs 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 239000004395 L-leucine Substances 0.000 description 3
- 235000019454 L-leucine Nutrition 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical group OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- -1 dextrin Chemical class 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 229960005190 phenylalanine Drugs 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- 235000014393 valine Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- SKAWDTAMLOJQNK-UHFFFAOYSA-N 2-acetamido-3-(4-hydroxyphenyl)propanoic acid ethyl ester Chemical compound CCOC(=O)C(NC(C)=O)CC1=CC=C(O)C=C1 SKAWDTAMLOJQNK-UHFFFAOYSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- ORTFAQDWJHRMNX-UHFFFAOYSA-M oxidooxomethyl Chemical compound [O-][C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-M 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 235000013930 proline Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- KEVYYIMVELOXCT-UHFFFAOYSA-N 2-[[2-[(2-azaniumyl-4-methylpentanoyl)amino]acetyl]amino]-3-phenylpropanoate Chemical compound CC(C)CC(N)C(=O)NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 KEVYYIMVELOXCT-UHFFFAOYSA-N 0.000 description 1
- QMOQBVOBWVNSNO-UHFFFAOYSA-N 2-[[2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]acetyl]amino]acetate Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(O)=O QMOQBVOBWVNSNO-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- DEFJQIDDEAULHB-UHFFFAOYSA-N Alanyl-alanine Chemical compound CC(N)C(=O)NC(C)C(O)=O DEFJQIDDEAULHB-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- LIWMQSWFLXEGMA-UHFFFAOYSA-N DL-Alanyl-DL-valine Chemical compound CC(C)C(C(O)=O)NC(=O)C(C)N LIWMQSWFLXEGMA-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- DKEXFJVMVGETOO-LURJTMIESA-N Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CN DKEXFJVMVGETOO-LURJTMIESA-N 0.000 description 1
- GGLIDLCEPDHEJO-BQBZGAKWSA-N Gly-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CN GGLIDLCEPDHEJO-BQBZGAKWSA-N 0.000 description 1
- XBGGUPMXALFZOT-VIFPVBQESA-N Gly-Tyr Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-VIFPVBQESA-N 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- SGCGMORCWLEJNZ-UWVGGRQHSA-N His-His Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1NC=NC=1)C([O-])=O)C1=CN=CN1 SGCGMORCWLEJNZ-UWVGGRQHSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical group CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Chemical group CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 1
- LCPYQJIKPJDLLB-UHFFFAOYSA-N Leucyl-leucine Chemical compound CC(C)CC(N)C(=O)NC(C(O)=O)CC(C)C LCPYQJIKPJDLLB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000061 acid fraction Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- CXISPYVYMQWFLE-UHFFFAOYSA-N alanylglycine Chemical compound CC(N)C(=O)NCC(O)=O CXISPYVYMQWFLE-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- QJVFWNHLKIAQAW-INIZCTEOSA-N benzyl N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamate Chemical compound NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)OCc1ccccc1 QJVFWNHLKIAQAW-INIZCTEOSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- MZDXDPNLELFVRH-UHFFFAOYSA-N calcium;2-hydroxy-4-methylsulfanylbutanoic acid Chemical compound [Ca+2].CSCCC(O)C(O)=O MZDXDPNLELFVRH-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 description 1
- 229940124568 digestive agent Drugs 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- IDQFMTPFABLANH-UHFFFAOYSA-L disodium 2-aminoacetic acid chloride hydroxide Chemical compound [OH-].[Na+].[Na+].[Cl-].NCC(O)=O IDQFMTPFABLANH-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- YIVZYFDBEPMPNL-LBPRGKRZSA-N ethyl (2s)-2-acetamido-3-phenylpropanoate Chemical compound CCOC(=O)[C@@H](NC(C)=O)CC1=CC=CC=C1 YIVZYFDBEPMPNL-LBPRGKRZSA-N 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002196 fr. b Anatomy 0.000 description 1
- 210000003918 fraction a Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- KZNQNBZMBZJQJO-YFKPBYRVSA-N glyclproline Chemical compound NCC(=O)N1CCC[C@H]1C(O)=O KZNQNBZMBZJQJO-YFKPBYRVSA-N 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N glycyl-DL-phenylalanine Chemical compound NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- 108010001064 glycyl-glycyl-glycyl-glycine Proteins 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- STKYPAFSDFAEPH-LURJTMIESA-N glycylvaline Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CN STKYPAFSDFAEPH-LURJTMIESA-N 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- KELXKDDAALYTDI-BTVCFUMJSA-N nitric acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound O[N+]([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O KELXKDDAALYTDI-BTVCFUMJSA-N 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 1
- QXADHXQCAQTNGW-UHFFFAOYSA-M sodium;boric acid;hydroxide Chemical compound [OH-].[Na+].OB(O)O QXADHXQCAQTNGW-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
- Y10S435/816—Enzyme separation or purification by solubility
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/832—Bacillus
- Y10S435/839—Bacillus subtilis
Definitions
- ABSTRACT A new, peptide-forming type of alkaline protease which is characteristically different from any similar commercial product in substrate specificity, decomposition pattern, amino acid composition, elementary analysis and other physicochemical properties, and which has the greatest enzymatic activity between pH 11.0 and [1.7.
- the invention 10 Claims, 1 Drawing Fig. U 8 Cl 195/62 includes a method of preparing said enzyme by cultivating "1.35/66 195/96, Bacillus bull-s varsakainensis (ATCC 21394), and by Punfy ing the crude enzyme preparation obtained therefrom at a Int. Cl C07g 7/028 larger yield in comparison with other commercially available Field of Search 195/62, 66 proteases, in crystal f by a very simplified method.
- This invention relates to a new alkaline protease and to the preparation thereof by cultivating a variety of spore-forming bacteria.
- proteases are commonly known as digestives or are utilized in the leather industry. But some proteases like chymotrypsin and. bromelin have recently proved extremely useful in other areas such as medical treatment and food and detergent additives. For example, they have gained public recognition for their efficacy when applied to medical treatment for wounded skin-lessening skin inflammation and removing discharges and deteriorated tissues from the inflamed region. It has been also known that they can be effectively employed as ingredients for meat tenderizers and for detergents for both dishwashing and laundry use. Accordingly, the demand for these prozeases has risen very rapidly.
- protease being produced from the above-named strain of microorganism was found to be a singular new kind, characteristically different from any known protease, similar in general properties, amino acid compositions, and substrate specificity, in particular. This protease was also found to be very easily crystallized in a few simple steps, as compared with other known proteases. This is a distinctive quality of this protease and is highly valued in its commercial applications.
- Vegetative cells microscopic observation under a tempera ture of28C. to 32 C. for 18 to 24 hours Rods, 0.8 to 1.0 by 2.5 to 3.5 microns; in some cases long rods, 0.8 to 1.0 by 5.0 to 6.0 microns, or filaments. Single or occasionally in short chains (2-4). Not encapsulated, but coated with slime. Motile. Gram-positive. Not vacuolated if lightly stained. Sometimes, shadow forms. Growth on glucose nutrient agar is nearly same as on nutrient agar; but, cells contain a few small fat globules.
- Spores circular to cylindrical, 0.7 to 1.0 by 1.0 to 1.3 microns, thin-walled, central or paracentral. Usually formed in 48 hours. Sporangia frequently show bipolar staining; and very little, if any, swelling by spores.
- Colonies on nutrient agar plates (46 hours). Circular or irregular, undulated, convex or evenly raised, rough, dull, opalescent, offwhite.
- Nutrient agar slants (48 hours, 30 C.). Good growth at l to 2 days; spreading, glistening (center) to dull (margin), undulated, offwhite, opalescent, odorless, no pigment formed in inedium, smooth. After 7 to 24 days, offwhite with slight olive color, translucent, glistening.
- Nutrient broth 14 days, 30 C.). Slight turbidity and sediment, pellicle not formed at beginning but slightly formed at 7 or 8 days.
- Nutrient gelatin slabs (1 month, C.). Liquefaction crateriform in early stage to stratiform in 7 to 8 days. Nearly completely liquefied in 20 days.
- Glucose nutrient agar slants (48 hours, 30 C.). Same or slightly better growth than on nutrient agar. White, glistening, viscoid. Transparent at aging. No change in color of medium.
- Soybean agar slants (48 hours, 30C.). Same growth as on nutrient agar. White, smooth, glistening, spreading, lobate or arborescent.
- Glucose asparagine agar slants (48 hours, 30 C.). Moderate growth somewhat inferior to that on nutrient agar.
- Glucose nitrate agar slants (14 days, 30 C.). Scant growth after 2 weeks.
- Potato plugs (14 days, 30 C.). Good growth, creamy white, smooth, glistening, somewhat raised. After 14 days, still smooth and more yellowish.
- NaCl broth (14 days, 30 C.). Growth in 5 or 7 percent NaCl, but not decisive in 10 percent.
- Salts (glucose agar streak): No growth, but moderate growth with biotin 10 to ug/l.
- Citrates utilized Nitrites produced from nitrates No gas produced in nitrate broth under anaerobic conditions.
- pH is 6.1 at 14 days.
- fructose sucrose, maltose, starch, inulin, glycerin, mannitol, sorbitol. No acid or gas produced from lactose.
- the strain isolated according to this invention was defined to be a new variety of the above-referred strain and thus named Bacillus substilis var sakainensis.
- a normal production of the proteolytic enzyme to which this invention relates can be attained by basically conventional microbial fermentation with the above-described strain; and submerged culture is the preferred method.
- the medium to be used can be synthetic, semisynthetic or natural, but it should contain the nutrient sources which can be assimilated by the above-described strain. More specifically, a medium is composed of carbohydrates as a carbon source, e.g., commercially obtainable glucose, glycerin, sucrose,starch, dextrine, molasses and maltose-glucose syrup;
- nitrogen sources e.g., commercially available peptone, meat extract, corn steep liquor, cottonseed meal, fish meal, soybean flour, casein-hydrolyzing material, yeast extract, dried yeast, gluten meal, ammonium sulfate, ammonium nitrate, urea and so forth.
- a suitable defoaming agent can be applied.
- the fermentation can be carried out at any temperature within the range in which said strain can grow and produce the desired enzyme. However, it can be most effectively carried out at between 25 and 37 C.
- the fermentation time in which a sufficient amount of the desired enzyme is accumulated in the medium, according to this invention ranges from 40 to 140 hours, varying with the modes of fermentation.
- a seed culture is prepared by inoculating the strain, which has been precultured on a nutrient agar slant, in a nutrient broth (pH 7.2), and cultivating the broth by shaking it at 33 C. for 16 to 20 hours.
- a percent soybean extractthe supernatant obtained by steaming grams of soybean meal in 100 ml. of distilled water, followed by extraction-is added to the nutrient broth, i.e. seed culture.
- Another nutrient broth used for the main culture medium contains 8 to percent carbohydrates such as dextrin, soluble starch and/or maltose-glucose syrup, in order to obtain a high yield of the protease.
- the content of the nitrogen source, such as polypeptone or meat extract, which is usually 1 percent may be brought up to 2 to 3 percent. This would subsequently cause an increase of the yield of said protease produced.
- the maximum amount of said protease i.e., 5 to 8 mg./ml., can be produced from 100 ml. of the above-prepared culture medium which has been cultivated in a 500 ml. Sakaguchi flask on a shaker having a 7 cm. stroke at 120 rpm, at 33 C. for 4 to 5 days.
- the enzyme accumulated in the medium when the cultivation is terminated is then collected in crystal form by various known methods.
- the following methods are normally employed in appropriate combination: fractionation by solubilities, e.g., salting-out, precipitation by organic solvent or by isoelectric point; separation by adsorption; and still others such as dialysis, precipitation by certain metallic salts, removal of other proteins present in the medium by denaturing them, ion-exchange resin treatment, Sephadex treatment, electrophoresis, ultracentrifugation and so on.
- One of the features of this invention is to collect crude crystals of this proteolytic enzyme by a relatively simple method and still at a higher yield.
- a filtrate of the broth is fractionally-precipitated by ammonium sulfate while the pH of the broth is adjusted with an ammonium solution to approximately 8.5.
- the precipitates are collected either by centrifuging or by filtration, adjusted by adding an ammonia solution to pH 10.0, and dissolved in the minimum required amount of distilled water.
- the enzyme solution at high concentration is added with l 10 by volume of Palitzsch buffer solution (pH 8.2) and then is readjusted to between pH 8.2 and 9.0 by adding an acetic acid solution, and thereafter held to cool.
- the enzyme in crystals of long hexagonal plates or rectangular plates is separated therefrom.
- the activity of the enzyme thus obtained accounts for 30 to 50 percent of the total activity of the concentrated enzyme solution before crystallization.
- the remaining enzyme solution is further precipitated by a 50 percent saturation of ammonium sulfate and treated by the same method, i.e., dissolving in a small amount of water with its pH adjusted and cooling it.
- the enzyme is further separated therefrom in crystalline forms, and the cumulative activity reaches to percent of the total activity of the original broth. Therefore, when suitable conditions are carefully chosen and applied, 5 to 6 grams of crude enzyme can be obtained from a liter of the broth.
- Such a simplified method of crystallization cannot be achieved with other known alkaline proteolytic enzymes produced from Bacillus subtilis.
- the crude enzyme thus obtained is further purified by washing, dissolving, pH adjustment by adding a borate buffer, and cooling.
- the yield of the pure final product is as high as 60 to 70 percent.
- said enzyme can be crystallized and separated out of the filtrate by simply adjusting the pH of the filtrate. But in that case, the yield is merely 2 to 3 percent of the total activity.
- the activity of the protease according to this invention is estimated by the Casein-Folin method. For example, 1.0 ml. of the sample protease-diluted with buffer solution and adjusted to bring the ultimate activity (measured by optical absorption at 660 mp.) within 0.1 to 0.5-is treated with 5.0 ml. of 1.2 percent casein solution, and the mixture is allowed to stand at 37 C. for 10 minutes. Then with 5.0 ml. of reagent B (a mixture containing 0.1 l Mols of CCl COOH, 0.22 Mols of CH COONa and 0.33 Mols of CH COOH) or reagent A (0.44 Mols of CCI COOH) added, it is held for an additional 30 minutes at 37 C. and thereafter filtered.
- reagent B a mixture containing 0.1 l Mols of CCl COOH, 0.22 Mols of CH COONa and 0.33 Mols of CH COOH
- reagent A (0.44 Mols of CCI COOH
- the enzymatic activity of the filtrate is estimated by optical absorption at 275 mu. This process is called a simplified" method in describing this invention.
- One ml. of the above filtrate is then added with 5 ml. of 0.44 Mols of NaCO solution and 1 ml. Folin reagent (X5 dilution), and the mixture is allowed to stand for 20 minutes at 37 C.
- the activity is estimated by optical absorption at 660 mp.
- Casein-Folin method For comparing enzymatic activities, the values expressed by the optical absorbancy at 660 mp. are directly applied, but the activities are usually expressed by the numerals converted to a value of 1 ml. of the original sample or of 1 mg. of the solid sample.
- the enzymes used for comparison in this invention are: a commercial product produced from Bacillus subtilis, and sold under the trade name Nagarse, which has been recrystallized three times (and is hereinafter referred to as enzyme N), and an alkaline protease produced from Bacillus subtilis var amylosacclzariricus, which has been recrystallized three times (hereinafter referred to as enzyme A).
- the proteolytic activity of the enzyme according to this invention was assayed by the Casein-Folin method at various pH values ranging from 6 to 13. As shown in table 1 below, the activity of said enzyme on casein is particularly high between pH 10 and 12, and its optimum is at pH 11.0 to 11.7. The above fact indicates that said enzyme is an alkaline proteolytic enzyme like the other enzymes, N and A, used for comparison.
- the optimum pH for the activity of said enzyme is even more alkaline than those for the others which are pH Table l 5 relationships of pH to proteolytic activity
- the enzyme solution is prepared by recrystallizing the crystals having the highest activity according to this invention five times (this procedure is used for all the experiments hereinafter described, unless otherwise noted), and dissolving these crystals in water, 0.07 mg./ml. 0.5 ml. of each of the above solutions is withdrawn and 2.5 ml. of 1.2 percent casein solution is added thereto at the appropriate pH (i.e., pH 5.8-8.2 adjusted with KH PO Borax, pH 9.2-10.4 with Borax-Na Co and pH l l.0l2.7 with glycine-NaCl-NaOH. Then, with 2 ml. of reagent A, the activities are estimated by Casein-Folin method as described hereinabove.
- said enzyme demonstrates a certain hydrolysis pattern with casein used as substrate, which is different from those of other known alkaline proteolytic enzymes. The comparison is made in table 2.
- the new enzyme which is also proteolytic produced from a strain of Bacillus subtilis has a higher substrate specificity, even closer to that of trypsin, thus indicating it is a peptide-forming type. Furthermore, these differences (substrate specificity and proteolytic pattern) between the new enzyme and the commercially available enzyme N become more obvious when the hydrolyzed substance of casein after hydrolysis by those enzymes are respectively fractionated on a Sephadex G--25 column. As in table 3, the substance hydrolyzed by enzyme N shows a higher peak for the 75 low-molecular, i.e., amino acid fraction, while that hydrolyzed by the new enzyme shows a peak only for the macromolecule, i.e., peptide fraction.
- subtilopeptidase A which demonstrates specificity towards such substrates as those containing L-leucine
- subtilopeptidase B which specificity is directed to the substrates containing L-tyrosine. It is accepted that enzyme N belongs to this latter type.
- the substrate specificity of the new enzyme was further tested in comparison with enzyme N (subtilopeptidase B) by the pH-Stadt method using the following synthetic substrates: acetyl-X-ethylester (X represents glycine, L-valine, L-norvaline, L-leucine, L-tyrosine, L-phenylalanine and L-lysine) and benzyl-L-arginine-ethylester.
- X represents glycine, L-valine, L-norvaline, L-leucine, L-tyrosine, L-phenylalanine and L-lysine
- benzyl-L-arginine-ethylester benzyl-L-arginine-ethylester.
- the new enzyme exhibited the maximum activity on acetyl-L-leucine-ethylester and considerable activity on acetyl-L-tyrosine-ethylester and acetyl-L- phenylalanine-ethylester, respectively.
- enzyme N reacted most on acetyl-L-tyrosine-ethylester but very little on acetyl-L-leucine-ethylester. The above results further distinguish the new enzyme from enzyme N and put it into the subtilopeptidase A type.
- the optimum pH for the activity of said enzyme at 37 C. is between 10.8 and 12.0, and the activity is maintained at 80 percent at pH 10.0 and nearly halved at pH 6 to 9 and at 12.5.
- the activity of said enzyme (per mg. of protein) at various pH values is further compared with the other enzymes, A and N, as in table 7 below wherein the relative activities of said enzyme and A are compared with the activity of N expressed as 100.
- the specific activity of said new enzyme (per mg.) differs from those of the others.
- the enzyme according to this invention ex- TABLE 12.EFFECTS 0F INHIBITORS ON ENZYMATIC hibited a great deal higher stability than the other known ACTIVITY IN COMPARISON WITH ENZYME A proteolytic enzymes produced from Bacillus subtilis, after a Newemyme longer storage period.
- table 108 there is no 00mm EnZYmeA change at all in the activity after the enzyme is left to react in Inhibitor nation (pH M) (pH (DH Palitzsch borate buffer (pH 8.2) for 10 days at 5 C., while the 100 100 100 100 other enzymes, N and A, lose 48 percent and I0 percent of HgC]; 1 10-aM their activities respectively.
- the enzymes, N and A are totally inac- EDTAII: 2X10 M tivated, while the new enzyme loses only 10 percent of its total gig-:1: activity.
- the enzymes, N and A used for this experi- PCMB 2x10 M ment, the commercially available sample crystals which cong f fj gfigifi tain some inactive material (approximately 30-40 percent), as Ascorbic acid 2X10- M shown in the FIGURE, are subjected to gel filtration prior to W the stability test against storage.
- the enzyme according to this invention which is completely inhibited by DFP, belongs to the serine enzyme group having serine at the center of their activity. And secondly, the activity of the new enzyme is less inhibited by metalic salts than enzyme A.
- amino acid composition of the enzyme according to this invention is distinguished from that of enzyme A BY its percentage of such amino acids as lysine,
- subtilopeptidase A which resembles said new enzyme in its subtilopeptidase Enzyme N A B Experimenta 11. 812. 2
- said enzyme strictly speaking can be distinguished from all other enzymes so far known and used for comparison, in terms of its enzy- Five ml. of soybean extract prepared in accordance with the procedures hereinbefore described is added to 100 ml. of nutrient broth containing 1.0 percent polypeptone, 1 percent meat extract and 0.3 percent NaCl. This is used as a seed culture medium, in which a loop of the culture of this strain relating to this invention precultured on a nutrient agar slant is inoculated. After an overnight incubation on a shaker at 33 C., it is ready to be used as a seed culture.
- the main culture medium is prepared by adding 10 percent soluble starch to the above-mentioned nutrient broth, and, after sterilization, it is poured into 260 Sakaguchi flasks having a capacity of 500 ml. Two ml. of the above-prepared seed culture is inoculated into each flask of the main culture medium and incubated on a shaker at 33 C.
- the enzymatic activity was determined with borate buffer solution (pH 8.2) as hereinbefore described in this specificat
- the culture broth is centrifuged to remove the cells and thereafter filtered.
- Ammonium sulfate is added to the 5.3 l. of the filtrate to make a 50 percent saturated solution while the filtrate is being adjusted to pH 8.5 to 9.5 with a 10 percent aqueous ammonia, thereby separating the enzyme protein.
- the precipitate is collected by centrifuge and dissolved in 500 ml. of distilled water while the pH is being adjusted with 10 percent aqueous ammonia to around 9.0 to 10.0. Then, the insoluble constituents are removed by centrifuge, and the supernatant is adjusted to pH 8.2 and held overnight in refrigerator, thereby separating the enzyme protein in crystal form.
- the mother liquid, together with the water with which crude crystals have been washed, is 50 percent saturated with ammonium sulfate, and the precipitate formed is collected by centrifuge. Following the procedures above described, 9.5 grams of crude crystals of the enzyme according to this invention was recovered from the mother liquid. Together with the previous yield, it amounted to 92 percent of the total activity.
- EXAMPLE 2 To 2.5 liters ofthe filtrate as obtained in example 1 is added 3.5 liters of acetone; the precipitate obtained is dissolved in 500 ml. of distilled water (pH 9.0) and further treated with ammonium sulfate to bring into 50 percent saturation. The precipitate is collected by centrifuge, and is crystallized according to the procedures as described in example 1. The yield of the crude enzyme before the mother liquid is recovered was 42 percent of the total activity.
- EXAMPLE 3 Twenty four grams of the crude crystal enzyme as obtained in example 1 was dissolved in a small amount of distilled water, while the pH was maintained between 9.0 and 10.0 with aqueous ammonia. Again adjusting the pH at 8.2 with acetic acid, it was recrystallized by holding it in a cool place. The crystals thus obtained were collected by centrifuge and rinsed repeatedly. As a result, 13.6 grams of the pure crystals were obtained.
- EXAMPLE 4 One hundred ml. of culture medium composed of 0.1 percent, K HPO 0.3 percent NaCl, 0.05 percent MgSO,-7H,O, 2.0 percent fishmeal, and 8.0 percent maltose-glucose syrup at a pH of 7.2 was introduced into a Sakaguchi flask and sterilized. Two ml. of the seed culture prepared as in example 1 was inoculated and cultivated for 5 days under the same cultural conditions as given in example 1. At the end of cultivation, 5.6 mg. per ml. of enzyme was accumulated in the medium.
- EXAMPLE 5 Cultivation under the same conditions as in example 1 was carried out in a medium comprising 2.0 percent polypeptone, 2.0 percent meat extract, 20 percent maltose-glucose syrup and 0.3 percent NaCl. After 5 days, 8.2 mg. per ml. of enzyme had accumulated in the medium.
- EXAMPLE 6 Five hundred ml. of the culture broth obtained in example 5 was adjusted to pH 8.5 by adding 50 ml. of Palitzsch borate buffer solution (pH 8.2) and held overnight in a cool place to separate the enzyme crystals. The crystals obtained were centrifuged, rinsed and dried. As a result, mg. of crude crystals were obtained, which accounted for 2.8 percent of the total activity.
- s20w means a value determined in terms of 20 (3., using water as a solvent.
- Friction ratio, f/fo jfrictional coefficient; f/fi)"frictional ratio Frictional force of a particle is proportioned to sedimentation rate, and its proportion constant is represented by f. of is frictional coefficient of a spherical particle of the same value as the above-referred particle and having no hydration.
- f/fo is often used in determining a frictional ratio and gives specific values to various substances.
- Viscosity is usually expressed by g./sec.cm.
- [1;] is expressed mostly by cmslg. and sometimes by dl./g., in which d1. is of course deciliter.
- Substrate specificity such as affinity for the carboxyl-radical side of L-leucyl of the peptide and ester bonds being stronger than affinities of other enzymes;
- a process for the production of a new alkaline protease in which a medium containing fishmeal as a nitrogen source, glucose-maltose syrup as a carbon source, and 0.1 percent K HPO 0.3 percent sodium chloride and 0.05 percent magnesium sulfate as inorganic salts is employed.
- a process for the production of a new alkaline protease in which a medium containing 2.0 percent polypeptone and 20 percent meat extract as a nitrogen source, 20 percent glucose-maltose syrup as a carbon source, and 0.3 percent sodium chloride as an inorganic salt is employed.
- a purification comprises the steps of fractionally precipitating the filtrate of the culture broth with ammonium sulfate at pH 8.5, collecting the precipitate by centrifugation or by filtration, adjusting thepH to 10.0, dissolving said precipitate in the minimum required 7.
- a process for the production of a new alkaline protease in which a purification comprises the steps of precipitating the filtrate of the culture broth by adding acetone, dissolving the precipitate in the minimum required amount of distilled water, fractionally precipitating with ammonium sulfate, collecting the precipitate by centrifugation or filtration, dissolving said precipitate in the minimum required amount of distilled water at pH 9.0, readjusting the solution to between pH 8.2 and 8.5 with Paliztsch borate buffer (pH 8.2) or acetic acid solution, and finally separating the enzyme produced in crystal form.
- a purification comprises the steps of precipitating the filtrate of the culture broth by adding acetone, dissolving the precipitate in the minimum required amount of distilled water, fractionally precipitating with ammonium sulfate, collecting the precipitate by centrifugation or filtration, dissolving said precipitate in the minimum required amount of distilled water at pH 9.0, readjusting the solution to between pH 8.2 and 8.5 with Paliztsch borate
- a process for the production of a new alkaline protease which comprises steps of adjusting the pH of the filtrate of the culture broth to 8.2 with Paliztsch borate buffer or acetic acid solution, and separating therefrom the enzyme in crystal forms.
- a process for the production of a new alkaline protease in which a purification comprises the steps of fractionally precipitating the filtrate of the culture broth with ammonium sulfate, collecting the precipitate by centrifugation or filtration, adjusting the pH to 9.0, dissolving it in the minimum required amount of distilled water, and purifying on a Sephadex column.
- a process for the production of a new alkaline protease in which a purification comprises the steps of precipitation the filtrate of the culture broth with a solvent selected from the group consisting of acetone, methanol and ethanol, adjusting the precipitate to pH 9.0, dissolving it in distilled water, again precipitating it with the above solvent, and separating the pure enzyme crystals.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
A new, peptide-forming type of alkaline protease which is characteristically different from any similar commercial product in substrate specificity, decomposition pattern, amino acid composition, elementary analysis and other physicochemical properties, and which has the greatest enzymatic activity between pH 11.0 and 11.7. The invention includes a method of preparing said enzyme by cultivating Bacillus subtilis var sakainensis (ATCC 21394), and by purifying the crude enzyme preparation obtained therefrom at a larger yield in comparison with other commercially available proteases, in crystal form, by a very simplified method.
Description
United States Patent Inventor Sawao Murao Sakai, Japan Appl. No. 861,911 Filed Sept. 29, 1969 Patented Nov. 23, 1971 Assignee Sanraku Ocean Co., Ltd. Tokyo, Japan Priority Oct. 2, 1968 Japan 43/7 1084 PRODUCTION OF A NEW PROTEASE Primary Examiner-Alvin E. Tanenholtz Attorney-Holcombe, Wetherill & Brisebois ABSTRACT: A new, peptide-forming type of alkaline protease which is characteristically different from any similar commercial product in substrate specificity, decomposition pattern, amino acid composition, elementary analysis and other physicochemical properties, and which has the greatest enzymatic activity between pH 11.0 and [1.7. The invention 10 Claims, 1 Drawing Fig. U 8 Cl 195/62 includes a method of preparing said enzyme by cultivating "1.35/66 195/96, Bacillus bull-s varsakainensis (ATCC 21394), and by Punfy ing the crude enzyme preparation obtained therefrom at a Int. Cl C07g 7/028 larger yield in comparison with other commercially available Field of Search 195/62, 66 proteases, in crystal f by a very simplified method.
(0ND/770/V! SHMPLE on 25019 memes:
mum/v zaxao cm ELUHTE //0 murzsy 50/?47'5 BUFFER s04 arm/v H52 v54 own /2 val/110a ALKALINE marmsa 05m: 702
NEW ENZYME /8,/ (lad/n9) RESl/L T:
llVflCT/VE POA770A/ OF PROTEIN aa zaa/r zu,
PRODUCTION OF A NEW PROTEASE SUMMARY OF THE INVENTION This invention relates to a new alkaline protease and to the preparation thereof by cultivating a variety of spore-forming bacteria.
Proteases are commonly known as digestives or are utilized in the leather industry. But some proteases like chymotrypsin and. bromelin have recently proved extremely useful in other areas such as medical treatment and food and detergent additives. For example, they have gained public recognition for their efficacy when applied to medical treatment for wounded skin-lessening skin inflammation and removing discharges and deteriorated tissues from the inflamed region. It has been also known that they can be effectively employed as ingredients for meat tenderizers and for detergents for both dishwashing and laundry use. Accordingly, the demand for these prozeases has risen very rapidly.
Specifically, the growing popularization of dishwashers and the consumption of enzyme-containing laundry detergents will have a decisive influence on the market for proteases. Considering the above-mentioned possibilities and the industrial demand to be met, applicant has sought to find a new and superior protease, and this search resulted in the discovery of an especially potent strain selected from numerous micro-organisms isolated from nature, which would produce a new protease far superior to any known in its yield and purity, and then in identifying said strain by its mycological characteristics as a new variety of Bacillus sub'tilis.
The protease being produced from the above-named strain of microorganism was found to be a singular new kind, characteristically different from any known protease, similar in general properties, amino acid compositions, and substrate specificity, in particular. This protease was also found to be very easily crystallized in a few simple steps, as compared with other known proteases. This is a distinctive quality of this protease and is highly valued in its commercial applications.
lt is believed that this invention, relating to the new and superior protease and a method of its production by cultivating a specific strain of micro-organism should find application in a wide range of industries.
The mycological characteristics of the above-mentioned specific strain relating to this invention will be given below:
1. Morphological characteristics Vegetative cells: microscopic observation under a tempera ture of28C. to 32 C. for 18 to 24 hours Rods, 0.8 to 1.0 by 2.5 to 3.5 microns; in some cases long rods, 0.8 to 1.0 by 5.0 to 6.0 microns, or filaments. Single or occasionally in short chains (2-4). Not encapsulated, but coated with slime. Motile. Gram-positive. Not vacuolated if lightly stained. Sometimes, shadow forms. Growth on glucose nutrient agar is nearly same as on nutrient agar; but, cells contain a few small fat globules.
Spores, circular to cylindrical, 0.7 to 1.0 by 1.0 to 1.3 microns, thin-walled, central or paracentral. Usually formed in 48 hours. Sporangia frequently show bipolar staining; and very little, if any, swelling by spores.
11. Cultural characteristics:
Colonies on nutrient agar plates: (46 hours). Circular or irregular, undulated, convex or evenly raised, rough, dull, opalescent, offwhite.
Nutrient agar slants": (48 hours, 30 C.). Good growth at l to 2 days; spreading, glistening (center) to dull (margin), undulated, offwhite, opalescent, odorless, no pigment formed in inedium, smooth. After 7 to 24 days, offwhite with slight olive color, translucent, glistening.
Nutrient broth": 14 days, 30 C.). Slight turbidity and sediment, pellicle not formed at beginning but slightly formed at 7 or 8 days.
Nutrient gelatin slabs: (1 month, C.). Liquefaction crateriform in early stage to stratiform in 7 to 8 days. Nearly completely liquefied in 20 days.
F RAZIER gelatin agar plate: (3 days, 30 C.). Wide zone of hydrolysis.
Glucose nutrient agar slants": (48 hours, 30 C.). Same or slightly better growth than on nutrient agar. White, glistening, viscoid. Transparent at aging. No change in color of medium.
Soybean agar slants: (48 hours, 30C.). Same growth as on nutrient agar. White, smooth, glistening, spreading, lobate or arborescent.
Glucose asparagine agar slants: (48 hours, 30 C.). Moderate growth somewhat inferior to that on nutrient agar.
Glucose nitrate agar slants: (14 days, 30 C.). Scant growth after 2 weeks.
Potato plugs: (14 days, 30 C.). Good growth, creamy white, smooth, glistening, somewhat raised. After 14 days, still smooth and more yellowish.
NaCl broth: (14 days, 30 C.). Growth in 5 or 7 percent NaCl, but not decisive in 10 percent.
Litmus milk: (30 days, 30 C.). Slightly acid at 2 days, peptonized at 4 days; medium remains acidic.
Milk (agar streak) plates: (48 hours, 30 C.). Good growth,
white, wide zone of hydrolysis of the casein.
Salts (glucose agar streak): No growth, but moderate growth with biotin 10 to ug/l.
*DIFCO products 111. Physiological characteristics:
Temperature: Optimum between 28 and 40 C. Maximum,
50 C. No growth at 55 and 10 C.
Catalase-positive Starch hydrolyzed Acetylmethylcarbinol produced Gelatin hydrolyzed Casein hydrolyzed pH of glucose broth is 5.2 to 5.4 at 7 days, at 30 C.
Citrates utilized Nitrites produced from nitrates No gas produced in nitrate broth under anaerobic conditions.
Growth scant in glucose broth under anaerobic conditions;
pH is 6.1 at 14 days.
Lecithinase not produced.
Acid but no gas from arabinose, xylose, mannose glucose,
fructose, sucrose, maltose, starch, inulin, glycerin, mannitol, sorbitol. No acid or gas produced from lactose.
Source; isolated from soil and natto" (or fermented soybean) Referring to Bergeys Manual ofDeterminative Bacteriology, 7th edition (1967), the above-described strain of micro-organism was identified to be a type of Bacillus subrilis from general characteristics. However, it differs from Bacillus subtilis in the following:
Subsequently, the strain isolated according to this invention was defined to be a new variety of the above-referred strain and thus named Bacillus substilis var sakainensis.
A normal production of the proteolytic enzyme to which this invention relates can be attained by basically conventional microbial fermentation with the above-described strain; and submerged culture is the preferred method.
The medium to be used can be synthetic, semisynthetic or natural, but it should contain the nutrient sources which can be assimilated by the above-described strain. More specifically, a medium is composed of carbohydrates as a carbon source, e.g., commercially obtainable glucose, glycerin, sucrose,starch, dextrine, molasses and maltose-glucose syrup;
and organic and inorganic nitrogen materials as a nitrogen source, e.g., commercially available peptone, meat extract, corn steep liquor, cottonseed meal, fish meal, soybean flour, casein-hydrolyzing material, yeast extract, dried yeast, gluten meal, ammonium sulfate, ammonium nitrate, urea and so forth. Frequently, it also contains inorganic salts such as sodium chloride, potassium chloride, calcium carbonate and magnesium sulfate. In case excessive foaming occurs during the fermentation, a suitable defoaming agent can be applied.
The fermentation can be carried out at any temperature within the range in which said strain can grow and produce the desired enzyme. However, it can be most effectively carried out at between 25 and 37 C. The fermentation time in which a sufficient amount of the desired enzyme is accumulated in the medium, according to this invention ranges from 40 to 140 hours, varying with the modes of fermentation.
Naturally, the optima of these cultural conditions, i.e. temperature and time, are carefully selected for the fermentation according to the properties of the strain used. Taking a more concrete example, a seed culture is prepared by inoculating the strain, which has been precultured on a nutrient agar slant, in a nutrient broth (pH 7.2), and cultivating the broth by shaking it at 33 C. for 16 to 20 hours. Sometimes a percent soybean extractthe supernatant obtained by steaming grams of soybean meal in 100 ml. of distilled water, followed by extraction-is added to the nutrient broth, i.e. seed culture. Another nutrient broth used for the main culture medium contains 8 to percent carbohydrates such as dextrin, soluble starch and/or maltose-glucose syrup, in order to obtain a high yield of the protease. ln addition, the content of the nitrogen source, such as polypeptone or meat extract, which is usually 1 percent, may be brought up to 2 to 3 percent. This would subsequently cause an increase of the yield of said protease produced. The maximum amount of said protease, i.e., 5 to 8 mg./ml., can be produced from 100 ml. of the above-prepared culture medium which has been cultivated in a 500 ml. Sakaguchi flask on a shaker having a 7 cm. stroke at 120 rpm, at 33 C. for 4 to 5 days.
The enzyme accumulated in the medium when the cultivation is terminated is then collected in crystal form by various known methods. For example, the following methods are normally employed in appropriate combination: fractionation by solubilities, e.g., salting-out, precipitation by organic solvent or by isoelectric point; separation by adsorption; and still others such as dialysis, precipitation by certain metallic salts, removal of other proteins present in the medium by denaturing them, ion-exchange resin treatment, Sephadex treatment, electrophoresis, ultracentrifugation and so on.
The crystallization of enzymes by means of any known method is generally accomplished through very complicated processes. Even though proteases could probably be crystallized by relatively simple methods as compared with other enzymes, they still have to go through several processes. For example, one method would take the following steps: fractional precipitation by ammonium sulfate-dialysis-ion-exchange resin treatment-adsorption on cellulose-elutionprecipitation-dialysis-crystallization. Such complication naturally leads to uneconomical results, lowering the total yield of the enzyme and raising the production cost.
One of the features of this invention is to collect crude crystals of this proteolytic enzyme by a relatively simple method and still at a higher yield. A filtrate of the broth is fractionally-precipitated by ammonium sulfate while the pH of the broth is adjusted with an ammonium solution to approximately 8.5. The precipitates are collected either by centrifuging or by filtration, adjusted by adding an ammonia solution to pH 10.0, and dissolved in the minimum required amount of distilled water. The enzyme solution at high concentration is added with l 10 by volume of Palitzsch buffer solution (pH 8.2) and then is readjusted to between pH 8.2 and 9.0 by adding an acetic acid solution, and thereafter held to cool. The enzyme in crystals of long hexagonal plates or rectangular plates is separated therefrom. The activity of the enzyme thus obtained accounts for 30 to 50 percent of the total activity of the concentrated enzyme solution before crystallization. The remaining enzyme solution is further precipitated by a 50 percent saturation of ammonium sulfate and treated by the same method, i.e., dissolving in a small amount of water with its pH adjusted and cooling it. Repeating the above processes, the enzyme is further separated therefrom in crystalline forms, and the cumulative activity reaches to percent of the total activity of the original broth. Therefore, when suitable conditions are carefully chosen and applied, 5 to 6 grams of crude enzyme can be obtained from a liter of the broth. Such a simplified method of crystallization cannot be achieved with other known alkaline proteolytic enzymes produced from Bacillus subtilis. The crude enzyme thus obtained is further purified by washing, dissolving, pH adjustment by adding a borate buffer, and cooling. The yield of the pure final product is as high as 60 to 70 percent. Other than the above-described methods, said enzyme can be crystallized and separated out of the filtrate by simply adjusting the pH of the filtrate. But in that case, the yield is merely 2 to 3 percent of the total activity.
In addition to the above-described procedures, the use of a Sephadex column simplifies the process even further. Such solvents as 60-70 percent acetone, ethanol and methanol may also be used in the precipitation method. The crystals ob tained by using these processes are of varied purity, ranging from 10 to percent. The purity of the product is not restricted by this invention.
The general enzymatic characteristics as well as the physicochemical properties of the enzyme produced according to this invention will be described in the following pages, which show that said enzyme is of a new type and quite different from other known types.
The activity of the protease according to this invention is estimated by the Casein-Folin method. For example, 1.0 ml. of the sample protease-diluted with buffer solution and adjusted to bring the ultimate activity (measured by optical absorption at 660 mp.) within 0.1 to 0.5-is treated with 5.0 ml. of 1.2 percent casein solution, and the mixture is allowed to stand at 37 C. for 10 minutes. Then with 5.0 ml. of reagent B (a mixture containing 0.1 l Mols of CCl COOH, 0.22 Mols of CH COONa and 0.33 Mols of CH COOH) or reagent A (0.44 Mols of CCI COOH) added, it is held for an additional 30 minutes at 37 C. and thereafter filtered. The enzymatic activity of the filtrate is estimated by optical absorption at 275 mu. This process is called a simplified" method in describing this invention. One ml. of the above filtrate is then added with 5 ml. of 0.44 Mols of NaCO solution and 1 ml. Folin reagent (X5 dilution), and the mixture is allowed to stand for 20 minutes at 37 C. Then the activity is estimated by optical absorption at 660 mp. This is the so-called Casein-Folin method. For comparing enzymatic activities, the values expressed by the optical absorbancy at 660 mp. are directly applied, but the activities are usually expressed by the numerals converted to a value of 1 ml. of the original sample or of 1 mg. of the solid sample.
The enzymes used for comparison in this invention are: a commercial product produced from Bacillus subtilis, and sold under the trade name Nagarse, which has been recrystallized three times (and is hereinafter referred to as enzyme N), and an alkaline protease produced from Bacillus subtilis var amylosacclzariricus, which has been recrystallized three times (hereinafter referred to as enzyme A).
( 1 Mode of action The proteolytic activity of the enzyme according to this invention was assayed by the Casein-Folin method at various pH values ranging from 6 to 13. As shown in table 1 below, the activity of said enzyme on casein is particularly high between pH 10 and 12, and its optimum is at pH 11.0 to 11.7. The above fact indicates that said enzyme is an alkaline proteolytic enzyme like the other enzymes, N and A, used for comparison. However, the optimum pH for the activity of said enzyme is even more alkaline than those for the others which are pH Table l 5 relationships of pH to proteolytic activity Note: The enzyme solution is prepared by recrystallizing the crystals having the highest activity according to this invention five times (this procedure is used for all the experiments hereinafter described, unless otherwise noted), and dissolving these crystals in water, 0.07 mg./ml. 0.5 ml. of each of the above solutions is withdrawn and 2.5 ml. of 1.2 percent casein solution is added thereto at the appropriate pH (i.e., pH 5.8-8.2 adjusted with KH PO Borax, pH 9.2-10.4 with Borax-Na Co and pH l l.0l2.7 with glycine-NaCl-NaOH. Then, with 2 ml. of reagent A, the activities are estimated by Casein-Folin method as described hereinabove.
In addition to the above, said enzyme demonstrates a certain hydrolysis pattern with casein used as substrate, which is different from those of other known alkaline proteolytic enzymes. The comparison is made in table 2.
Table 2 Hydrolysis Patterns of Three Enzymes using Casein as Note: The simplified method as hereinbefore described is employed. A and B in the above table express the activities determined by reagents A and B respectively. And, specifically, A expresses the amount of amino acid produced as result of hydrolysis; and B, the total amount of hydrolysis, i.e., those of peptide and amino acid. Therefore, (BA)/B indicates the ratio of peptides produced against the total amount of hydrolysis. (Hagihara: ibid., 305) It is known that proteolytic enzyme produced from Bacillus subtilis has a low substrate specificity, which indicates it is an amino-acid-producing type. This is shown by the enzyme N as in table 2. But the new enzyme which is also proteolytic produced from a strain of Bacillus subtilis has a higher substrate specificity, even closer to that of trypsin, thus indicating it is a peptide-forming type. Furthermore, these differences (substrate specificity and proteolytic pattern) between the new enzyme and the commercially available enzyme N become more obvious when the hydrolyzed substance of casein after hydrolysis by those enzymes are respectively fractionated on a Sephadex G--25 column. As in table 3, the substance hydrolyzed by enzyme N shows a higher peak for the 75 low-molecular, i.e., amino acid fraction, while that hydrolyzed by the new enzyme shows a peak only for the macromolecule, i.e., peptide fraction.
Table 3 New Enzyme Fraction Enzyme N Fraction A (high peptide) 76% 53% Fraction B (low peptide amino acid) 24 47 From the above, it can be concluded that the new enzyme has the optimum pH further toward the alkali side than any of the known alkaline proteases and is peptide-forming having the required substrate specificity, while the others are aminoacid-forming having no or low substrate specificity. And these properties single this new enzyme out of other alkaline proteases, as an entirely new enzyme.
(2) Substrate Specificity Using various proteins, the substrate specificity of the enzyme utilized in this invention was tested in comparison with the enzymes A and N, and the results are shown in table 4 below.
Table 4 Study on Substrate Specificity Relative Reaction Initial Rate Substrate new enzyme A N Milk casein Hill IOU Egg white albumin 43 6 J3 Gelatin I66 I55 I48 Soybean protein 54 59 4t) Gluten I09 97 R7 Haemoglobin I02 1 I2 I04 Note: 20 ml. of the mixture. in which various proteins 100 mg.) and enzymes (2 mg. each) are dissolved in M boric acid-sodium hydroxide buffer, is allowed to stand for 30 hours at 37 C. and thereafter assayed by the ninhydrin method.
As the above table shows, a large degree of disparity among the three enzymes is seen in the initial rate of the reaction on egg white albumin; that of the new enzyme is distinctively larger than that of A, and somewhat larger than that of N.
According to M. Ottesen et al. (Compt. Rend. Trav. Lab. Carlsberg, 34, 199: 1964), the alkaline proteases produced from B. subtilis can be generally divided into two major types in substrate specificity: (l subtilopeptidase A which demonstrates specificity towards such substrates as those containing L-leucine, and (2) subtilopeptidase B whose specificity is directed to the substrates containing L-tyrosine. It is accepted that enzyme N belongs to this latter type.
The substrate specificity of the new enzyme was further tested in comparison with enzyme N (subtilopeptidase B) by the pH-Stadt method using the following synthetic substrates: acetyl-X-ethylester (X represents glycine, L-valine, L-norvaline, L-leucine, L-tyrosine, L-phenylalanine and L-lysine) and benzyl-L-arginine-ethylester. The new enzyme exhibited the maximum activity on acetyl-L-leucine-ethylester and considerable activity on acetyl-L-tyrosine-ethylester and acetyl-L- phenylalanine-ethylester, respectively. On the other hand, enzyme N reacted most on acetyl-L-tyrosine-ethylester but very little on acetyl-L-leucine-ethylester. The above results further distinguish the new enzyme from enzyme N and put it into the subtilopeptidase A type.
In conclusion, the hydrolytic activities of three enzymes on various synthetic peptides and amino-acid ester chains used as substrates are summarized systematically as in table 5 below:
Table 5 Study on Substrate Specificity New Enzyme Enzyme No. Substrate Enzyme A N (Amino Acid esteis) lL-phenylalanyl-ethyl 2 L-tyrosyl-ethyl 3 N-acetyl-L-tyrosyl-ethyl (Dipeptides) 4 Glycyl-glycine 5 GlycyLDL-alanine 6 Glycyl-DL-valine 7 Glycyl-L-leucine 8 Glycyl-L-proline 9 Glycyl-L-tyrosine l Glycyl-DL-phenylalanine l I DL-alanyl-glycine l2 DL-alanyl-DL-valine l3 L-leucyl-L-tyrosinc l4 DL-leucyl-DL-leucine l Histidyl-histidine l6 L-leucyl-bphenylalanine l7 N-CBZ'L-vulyl-L-alanine 18 N-CBZ-L-valyl-L-proline l9 N-CBZ-L-valyl-L-leucine 20 N-CBZ-L-glycyl-L-tyrosinc 2| N-CBZglycyl-L-phenylalanine 22 N-CBZ-glycyl-L-phenylalanineamide 23 N-CBZ-leucyl-L-leucineamide 24 N-CBZ-tyrosyl-glycineamide (Tripeptides) 25 Glycyl-glycyl-glycinc 26 Glycyl-L-prolyl-L-alanine 27 L-leucyl-glycyl-glycine 28 DL-ulunyl-glycyl-glycinc 29 DL-leucyl-glycyl-DL-phenyl alanine 30 Glututhione (glutumylcystinylglycinc 31 N-CBZ-Lwalyl-glycylglycine-benzylester (Tctrapeptide) 32 Glycyl-glycyl-glycylglycine Note: A mixture of a substrate (2.0 mg.) and borate buffer (0.4 ml., pH 8.5, containing 100 ug. of enzyme) was left to react for 20 hours at 37 C., and a suitable amount of the reaction mixture was assayed by either a thin-layer chromatography with silicagel or by paper chromatography to identify amino acids and derivatives thereof obtained as results of the enzymatic reaction.
In table 5, the differences in substrate specificity among three enzymes are seen with respect to numbers, 2, 3, 24 and 27. That is, the new enzyme differs from N in activity rate in reacting towards the carboxyl side of L-tyrosine (Nos. 2, 3 and 24); and the new enzyme reacts on the carboxyl-radical side of L-leucine to decompose the peptide link while the other two do not (No. 27).
(3) Effect of pH on the enzymatic activity and stability Using casein as the substrate, the effect of pH on the enzymatic activity was tested with the enzyme according to this invention, and the results are shown in table 6.
Table 6 Effect of pH on the Enzymatic Activity Note: The following butters were employed for the adjustment of various pH values: M/50 sodium veronal, M/50 hydrochloric acid (pH 6.5-8.6) M/2O sodium borate, M/20 sodium carbonate (pH 8.9-l0.8) M/ 10 sodium hydroxide, M/lO disodium phosphate (pH 9.9-l2.5) Other conditions are same as described in the note for table 1.
Summarizing the above, the optimum pH for the activity of said enzyme at 37 C. is between 10.8 and 12.0, and the activity is maintained at 80 percent at pH 10.0 and nearly halved at pH 6 to 9 and at 12.5. The activity of said enzyme (per mg. of protein) at various pH values is further compared with the other enzymes, A and N, as in table 7 below wherein the relative activities of said enzyme and A are compared with the activity of N expressed as 100. Again, as is clear in the table below, the specific activity of said new enzyme (per mg.) differs from those of the others.
Table 7 Specific Activities of the Enzymes at Various pH values pH values Enzyme 7.4 8.5 10.5 11.5 Opt.
Table 8 Effect of pH on the Enzymatic Stability Residual Activity pH (Index No.)
4.0 negligible 5.0 negligible 6.0 negligible 45 8.0 98 9.0 98 9.5 98 10.5 98 10.8 98 l 1.0 75 l 1.5 35 l 1.8
negligible The te'mperature-activity relationship of the enzyme according to this invention was examined, and the result is shown in table 9, below:
mined at pH 8.5 after the times of storage, with toluene at the specific temperatures and specific periods of time given in the following table:
Table 9 TABLE B.COMPARATIVE STUDY ON STABILITY AGAINST STORAGE Temperature and Enzymatic Activity Resid' activity percent after Enzyme 10 days, 5 C. 10 hr., 30 C. hr., 30 C. Enzymatic Addition 10 Temperature Activity of Calcium g enzyme 23 gg 8 C. (index No.) lon (M/ZSO Cu") 9O 50 0 40 22 45 42 (6) The effects of pH and temperature on enzymatic action :2 g; :2 As discussed above, the new enzyme according to this in- 60 100 I vention remains perfectly stable between pH 8 and 10.5, at 65 95 :20 C. But at pH 7 or 1 1, its stability is somewhat lost, and 70 20 149 20 further at pH 6 or 12, it is completely lost. In relation to tem- Zg Negligible if: perature, said enzyme in solution at pH 8.2 shows stability for 90 Negligible 25 a short time at 40 C. or below. But it becomes somewhat unstable between 45 and 55 C. and extremely so between 60 and 65 C.; and finally it is inactivated at 70 C. As for a longer Note: pH 10.5 adjusted with borate buffer solution; reaction 25 Storage Stability Said enzyme remains highly Stable at a 10W time minutes temperature, e.g., 5 C. for 10 days; and is still 90 percent ac- Summarizing the above, h new enzyme reacts between tive after 20 hours, at 30 C. The other enzymes tested in comroom temperature and 70 C.; but the optimum temperature Parison under the conditions for 20 hours) gave for the enzymatic reaction is 55 to 65 C., and the maximum totally negative results- 60 C. In the presence of the calcium ion (4 l0 M), how- 30 (7) Inhibitors and their effects ever, the stability of said new enzyme increases to the First, the effects of various buffer solutions on the activity of imum of I40 percent at 70 C. 0n the other hand, the reaction the enzyme according to this invention were examinei and of enzyme A reaches its maximum at 55 C. (pH 10.5) and, in the results are Show" in table 1 it below the presence of the calcium ion (4Xl0 M), at 62 C. with only a 70 percent increase. (Fukumoto, Agricultural and Table l l Biological Chemistry, 30, I261: l966) The table below shows the stability of said new enzyme against temperature:
Effects of Bufi'ers on Enzymatic Activity Table 10A 0 Buffers pH 7.4 pH91) Temperature Stability Wsmimcl M/20 Nu,ta,o,-M/s 14,110,. Temperature Residual Actlvlty Mlzo MIC 93 83 45 M/l5 xH,Po,-M/1s mmpo, 88-91 66 7l M/lO Veronul-M/IO HCI 80-82 77-85 35 [00 MIN) Nu,co ,-M/10 H m... KCl 90 74 40 MIN) NH,OH-M/l0 NH,cl. 100 as so as 55 12 60 l 5 The above results show that the activity of said enzyme IS in- 65 5 hibited by the following buffers: Siirensen's KH PO -Na, 70 lz z HPO and NH OH-NH Cl buffer solution, at pH 9.0. Then,
again, the activity of said enzyme was tested with various inhibitors under the following conditions: pH 7.4 and 9.0, at 37 Note: The enzyme is dissolved in Palitzsch buffer solution C., for 30 minutes. Table 12 below gives the results as follows:
(pH 8.5) and left to react for 15 minutes.
Furthermore, the enzyme according to this invention ex- TABLE 12.EFFECTS 0F INHIBITORS ON ENZYMATIC hibited a great deal higher stability than the other known ACTIVITY IN COMPARISON WITH ENZYME A proteolytic enzymes produced from Bacillus subtilis, after a Newemyme longer storage period. As shown in table 108, there is no 00mm EnZYmeA change at all in the activity after the enzyme is left to react in Inhibitor nation (pH M) (pH (DH Palitzsch borate buffer (pH 8.2) for 10 days at 5 C., while the 100 100 100 other enzymes, N and A, lose 48 percent and I0 percent of HgC]; 1 10-aM their activities respectively. Again, when allowed to react for ggg ifigjgx 20 hours at 30 C., the enzymes, N and A, are totally inac- EDTAII: 2X10 M tivated, while the new enzyme loses only 10 percent of its total gig-:1: activity. As for the enzymes, N and A, used for this experi- PCMB 2x10 M ment, the commercially available sample crystals which cong f fj gfigifi tain some inactive material (approximately 30-40 percent), as Ascorbic acid 2X10- M shown in the FIGURE, are subjected to gel filtration prior to W the stability test against storage. [The portion of the active Note: DFP-di-isopropylfluorophosphate peaks of the respective enzymes are added with lO-time EDTA-4-acetic acid volume dilution of Palitzsch borate buffer (pH 8.2) to adjust MIA-monoiodoacetic acid SLS--Sodium lauryl sulfate the protein content] and their residual activities are deter- PCMB-parachloromercury benzoic acid BKClchloride The above inhibitors were respectively added to the reaction mixture containing 20mM Tris-HCl buffer (pH 7.4) and borate buffer solution (pH 9.0), and the mixture was allowed to stand at 37 C. for 30 hours.
From the above results, it is clear that the enzyme according to this invention, which is completely inhibited by DFP, belongs to the serine enzyme group having serine at the center of their activity. And secondly, the activity of the new enzyme is less inhibited by metalic salts than enzyme A.
(8) Purification Reference is made to the previous description and to the examples hereinafter set forth for the details in this point. As described therein, the simplified and economical method is employed, by which 4 to g. of crude enzyme is collected from a liter of the filtrate of cultured broth by fractional precipitation with ammonium sulfate, according to this invention. Then after recrystallization of the above crude crystals three times, 3 to 3.5 g. of the pure crystal enzyme is obtained. The accumulation of the enzyme in this invention is as high as 6 to 8 mg. per ml. of the medium, the crystallization of which enzyme can be simply accomplished by adjusting the pH of the medium. Considering this feature only, therefore, the advantage of this invention is clearly seen in its high yield of the enzyme and in the simple process of purificiation by crystallization.
(9) Physicochemical characteristics TABLE 13 Table l 4 Mobility in Electrophoresis (unit cmP/V sec.)
Item New enzyme Enzyme A pH Mobility p.
8.55 7.3lXl0'AH6 9.0 4.45xl0'AH6 9.5 3.28Xl0AH6 10.0 0
l5 12) Elementary analysis Reference is made to item 9. l3) Composition of amino acids The amino acid composition of the enzyme according to this invention is compared with those of other enzymes as in table 15, below:
Summarizing the above, the amino acid composition of the enzyme according to this invention is distinguished from that of enzyme A BY its percentage of such amino acids as lysine,
histidine, aspartic acid, serine, glycine, alanine, valine, leucine, and tyrosine; and from enzyme N and subtilopeptidase B by its percentage of lysine, histidine, arginine, threonine, isoleucine, serine, and tyrosine. It is differentiated from subtilopeptidase A which resembles said new enzyme in its subtilopeptidase Enzyme N A B Experimenta 11. 812. 2
Calculated. 12. 0 Sedimentation (10- sec.) 2. 94 Partial specific volu Experimental. 0.76
C ulculated 0. 73 ISO-electric point p1{) 10. 0-10.15 7. 5-8. 0 Molecular weight 29.0)(10 -30.0X10 22. 7X10 Friction ratio, f/fo 1. 17-1. 18 1. 04 Specific activity (unit/mg. protein). 2.4)(10 2.3)(10 Terminal amino acid Alanine Alanine Elementary analysis, percent:
N 14-15 15. 00 Ash 0.3-0. 7 1.
27. 7x10 30. 0X10 1. 18 1. 14 2.2)(10 Alanine Note: The source for the data on the enzymes A, N and Subtilopeptidase A and B is: Fukumoto, Agriculture and Biological Chemistry, 31,330: 1967. The sample enzymes used for the experiments are crystals which have been recrystallized three times or lyophilized samples thereof. For the ultracentrifuge, electrophoresis, and intrinsic viscosity tests, the samples were dialyzed overnight in a cool place against appropriate buffer solutions.
(10) Molecular weight The molecular weight of the enzyme according to this invention was calculated as below, following the formula by Sheraga and Mandelkern:
Sedimentation coefficient S=3.23 Intrinsic viscosity [u]=0.033 dl./g. Viscosity ofsolvent v=0.9032 Partial specific volume V=0.73 cm./g. Axial ratio =4 B=2.20 X10 Mol. wt. 29,000-30,000 The molecular weight of the new enzyme obtained by the above process can be compared with those of the other enzymes, A and N, in table 13, which are 22,700 and 27,700 respectively. l l Mobility in electrophoresis Table 14 shows the mobility in electrophoresis of the enzyme according to this invention at pH 8.5 to 10.0
TABLE 16.AMINO ACID COMPOSITION OF ENZYMES IN COMPARISON subtilopeptidase New Enzyme Enzyme Ammo acid enzyme A N A 13 Lysine ll 6 11 E1 11 Histidine 6 5 6 5 6 Arginine 4 3 2 4 2 28 20 28 31 20 18 14 14 20 13 41-44 37 38 37 38 13 10 14 J 15 16 12 16 12 15 38 25 34 3.) 34 36 27 38 43 38 0 0 0 0 0 30 2!) 30 35 31 5 3 5 (i 5 17 12 13 11 13 16 12 15 17 15 12 0 10 13 10 3 2 3 4 3 Tryptophene 4-5 3 4 3 1 Molecular wt. 27,700 30,000 28,000
behavior with synthetic substrates by the residual quantities of asparatic acid, serine, proline, glutamic acid, alanine, valine, trylophan.
From the various aspects described above, said enzyme strictly speaking can be distinguished from all other enzymes so far known and used for comparison, in terms of its enzy- Five ml. of soybean extract prepared in accordance with the procedures hereinbefore described is added to 100 ml. of nutrient broth containing 1.0 percent polypeptone, 1 percent meat extract and 0.3 percent NaCl. This is used as a seed culture medium, in which a loop of the culture of this strain relating to this invention precultured on a nutrient agar slant is inoculated. After an overnight incubation on a shaker at 33 C., it is ready to be used as a seed culture.
The main culture medium is prepared by adding 10 percent soluble starch to the above-mentioned nutrient broth, and, after sterilization, it is poured into 260 Sakaguchi flasks having a capacity of 500 ml. Two ml. of the above-prepared seed culture is inoculated into each flask of the main culture medium and incubated on a shaker at 33 C.
During the cultivation, the pH of the medium, the growth of the cells, and the enzymatic activity were measured in relation to the period of cultivation as shown in Table 16.
TABLE 16 Cultivation period (days) pH 6.8 6.4 6.4 6.3 6.2 Growth of the cell (absorbancy at 610 m 13. 2 17.3 21.0 21.0 20. 4 Enzymatic activity (absorbancy at 660 m 4. 6 13.3 19. 1 26. 2 25.3
The enzymatic activity was determined with borate buffer solution (pH 8.2) as hereinbefore described in this specificat|on.
When the cultivation is terminated. the culture broth is centrifuged to remove the cells and thereafter filtered. Ammonium sulfate is added to the 5.3 l. of the filtrate to make a 50 percent saturated solution while the filtrate is being adjusted to pH 8.5 to 9.5 with a 10 percent aqueous ammonia, thereby separating the enzyme protein. After the above has been held overnight in refrigerator, the precipitate is collected by centrifuge and dissolved in 500 ml. of distilled water while the pH is being adjusted with 10 percent aqueous ammonia to around 9.0 to 10.0. Then, the insoluble constituents are removed by centrifuge, and the supernatant is adjusted to pH 8.2 and held overnight in refrigerator, thereby separating the enzyme protein in crystal form.
The crystals obtained were collected by centrifuge, suspended in a l/lO Palitzsch borate buffer, again and repeatedly centrifuged, and finally rinsed. Thus, 14.6 grams of crude enzyme crystals were obtained. This yield is 58 percent of the total activity of the filtrate.
The mother liquid, together with the water with which crude crystals have been washed, is 50 percent saturated with ammonium sulfate, and the precipitate formed is collected by centrifuge. Following the procedures above described, 9.5 grams of crude crystals of the enzyme according to this invention was recovered from the mother liquid. Together with the previous yield, it amounted to 92 percent of the total activity.
EXAMPLE 2 To 2.5 liters ofthe filtrate as obtained in example 1 is added 3.5 liters of acetone; the precipitate obtained is dissolved in 500 ml. of distilled water (pH 9.0) and further treated with ammonium sulfate to bring into 50 percent saturation. The precipitate is collected by centrifuge, and is crystallized according to the procedures as described in example 1. The yield of the crude enzyme before the mother liquid is recovered was 42 percent of the total activity.
EXAMPLE 3 Twenty four grams of the crude crystal enzyme as obtained in example 1 was dissolved in a small amount of distilled water, while the pH was maintained between 9.0 and 10.0 with aqueous ammonia. Again adjusting the pH at 8.2 with acetic acid, it was recrystallized by holding it in a cool place. The crystals thus obtained were collected by centrifuge and rinsed repeatedly. As a result, 13.6 grams of the pure crystals were obtained.
EXAMPLE 4 One hundred ml. of culture medium composed of 0.1 percent, K HPO 0.3 percent NaCl, 0.05 percent MgSO,-7H,O, 2.0 percent fishmeal, and 8.0 percent maltose-glucose syrup at a pH of 7.2 was introduced into a Sakaguchi flask and sterilized. Two ml. of the seed culture prepared as in example 1 was inoculated and cultivated for 5 days under the same cultural conditions as given in example 1. At the end of cultivation, 5.6 mg. per ml. of enzyme was accumulated in the medium.
EXAMPLE 5 Cultivation under the same conditions as in example 1 was carried out in a medium comprising 2.0 percent polypeptone, 2.0 percent meat extract, 20 percent maltose-glucose syrup and 0.3 percent NaCl. After 5 days, 8.2 mg. per ml. of enzyme had accumulated in the medium.
EXAMPLE 6 Five hundred ml. of the culture broth obtained in example 5 was adjusted to pH 8.5 by adding 50 ml. of Palitzsch borate buffer solution (pH 8.2) and held overnight in a cool place to separate the enzyme crystals. The crystals obtained were centrifuged, rinsed and dried. As a result, mg. of crude crystals were obtained, which accounted for 2.8 percent of the total activity.
Explanation of some symbols and units of physical constants used in this specification: l. Sedimentation coefficient, s20w Order of sedimentation coefficient is l0"sec., and not l0 '"/sec.
s20w means a value determined in terms of 20 (3., using water as a solvent.
2. Friction ratio, f/fo jfrictional coefficient; f/fi)"frictional ratio Frictional force of a particle is proportioned to sedimentation rate, and its proportion constant is represented by f. of is frictional coefficient of a spherical particle of the same value as the above-referred particle and having no hydration.
The term, f/fo, is often used in determining a frictional ratio and gives specific values to various substances.
3. Intrinsic viscosity, [1;]
Viscosity is usually expressed by g./sec.cm.
However, intrinsic viscosity is entirely of another dimension, and the use of the word, viscosity, may not be appropriate. Therefore, [1;] is expressed mostly by cmslg. and sometimes by dl./g., in which d1. is of course deciliter.
4. Partial specific volume, [V 1 It is defined as a voluminal increase of the liquid when 1 gram of a certain substance is dissolved in an ample amount ofliquid, and it is expressed by cm./g.
What is claimed is:
1. A new alkaline protease which is characterized by it capability of being crystallized by simple process and which has the following properties:
a. Substrate specificity such as affinity for the carboxyl-radical side of L-leucyl of the peptide and ester bonds being stronger than affinities of other enzymes;
b. Active pH between 6.0 and 13.0, optimum pH from 10.5 to 11.0, stability maintained between pH 8.0 and 10.5,
and inactivation at pH 6.0 or below and pH 12.0 or above (at 30 C.
c, Active temperature between room temperature and 70 C., optimum temperature between 55 and 65 C., stability maintained at between 5 and 30 C., and inactivation at 70 C. or above (pH 8.2);
d. Serine protease type having serine at its center of activity,
which is inhibited by di-isopropyl fluorophosphate;
e. The following physical and chemical properties:
Absorbancy (Elcm.) R80 my. Sedimentation coefl'lcient (r20w) Intrinsic viscosity (1 Partial specific volume Isa-electric point Molecular weight 29.0X l-30.0Xl0 Friction ratio (f/fu) l.l7-l l 8 Specific activity 2.4x I0 f. Elementary analysis: C, 47-48percent; H, 6.5-7.2 percent; N, 14-15 percent; and Ash, 0.3-0.7 percent; and g. The following amino acids composition:
Lysine 9 Histidine 6 Arginine 4 Aspartic acid 28 Threonine l8 Serine 4]44 Proline l3 Glutamic acid [6 Glycine 38 Alanine 36 Half-cystine 0 Valine 30 Methionine lsoleucine l7 Leucine l6 Tyrosine l2 Phenylalanine 3 Tryptophan 4-5 Molecular weight 30,000
2. A process for the production of a new alkaline protease as claimed in claim 1, which comprises steps of inoculating Bacillus subtilis var sakainensis (ATCC 2l394) in a medium containing at least one carbon source selected from the group consisting of glucose, glycerine, cane sugar, starch, dextrin, molasses, and glucose-maltose syrup, at least one nitrogen source selected from the group consisting of peptone, meat extract, CSL, cotton seed meal, ammonium phosphate, urea, and ammonium nitrate, and inorganic salts; of cultivating the said strain of micro-organism under aerobic conditions at pH 6.0 to 8.0 and at a temperature between 25 and 37 C.; accumulating the new alkaline protease in the medium; and purifying said protease by combining more than one process selected from the group consisting of salting-out, precipitation with solvent; precipitation by l.E.P., absorption, dialysis, ionexchange resin treatment, and Sephadex treatment.
3. A process for the production of a new alkaline protease, according to claim 2, in which a medium containing 1 percent polypeptone and 1 percent meat extract as a nitrogen source 10 percent soluble starch as a carbon source, and 0.3 percent sodium chloride as an inorganic salt is employed.
4. A process for the production of a new alkaline protease, according to claim 2, in which a medium containing fishmeal as a nitrogen source, glucose-maltose syrup as a carbon source, and 0.1 percent K HPO 0.3 percent sodium chloride and 0.05 percent magnesium sulfate as inorganic salts is employed.
5. A process for the production of a new alkaline protease, according to claim 2, in which a medium containing 2.0 percent polypeptone and 20 percent meat extract as a nitrogen source, 20 percent glucose-maltose syrup as a carbon source, and 0.3 percent sodium chloride as an inorganic salt is employed.
. A process for the production of a new alkaline protease,
according to claim 2, in which a purification comprises the steps of fractionally precipitating the filtrate of the culture broth with ammonium sulfate at pH 8.5, collecting the precipitate by centrifugation or by filtration, adjusting thepH to 10.0, dissolving said precipitate in the minimum required 7. A process for the production of a new alkaline protease, according to claim 2, in which a purification comprises the steps of precipitating the filtrate of the culture broth by adding acetone, dissolving the precipitate in the minimum required amount of distilled water, fractionally precipitating with ammonium sulfate, collecting the precipitate by centrifugation or filtration, dissolving said precipitate in the minimum required amount of distilled water at pH 9.0, readjusting the solution to between pH 8.2 and 8.5 with Paliztsch borate buffer (pH 8.2) or acetic acid solution, and finally separating the enzyme produced in crystal form.
8. A process for the production of a new alkaline protease, according to claim 2, which comprises steps of adjusting the pH of the filtrate of the culture broth to 8.2 with Paliztsch borate buffer or acetic acid solution, and separating therefrom the enzyme in crystal forms.
9. A process for the production of a new alkaline protease, according to claim 2, in which a purification comprises the steps of fractionally precipitating the filtrate of the culture broth with ammonium sulfate, collecting the precipitate by centrifugation or filtration, adjusting the pH to 9.0, dissolving it in the minimum required amount of distilled water, and purifying on a Sephadex column.
10. A process for the production of a new alkaline protease, according to claim 2, in which a purification comprises the steps of precipitation the filtrate of the culture broth with a solvent selected from the group consisting of acetone, methanol and ethanol, adjusting the precipitate to pH 9.0, dissolving it in distilled water, again precipitating it with the above solvent, and separating the pure enzyme crystals.
Claims (9)
- 2. A process for the production of a new alkaline protease as claimed in claim 1, which comprises steps of inoculating Bacillus subtilis var sakainensis (ATCC 21394) in a medium containing at least one carbon source selected from the group consisting of glucose, glycerine, cane sugar, starch, dextrin, molasses, and glucose-maltose syrup, at least one nitrogen source selected from the group consisting of peptone, meat extract, CSL, cotton seed meal, ammonium phosphate, urea, and ammonium nitrate, and inorganic salts; of cultivating the said strain of micro-organism under aerobic conditions at pH 6.0 to 8.0 and at a temperature between 25* and 37* C.; accumulating the new alkaline protease in the medium; and purifying said protease by combining more than one process selected from the group consisting of salting-out, precipitation with solvent; precipitation by I.E.P., absorption, dialysis, ion-exchange resin treatment, and Sephadex treatment.
- 3. A process for the production of a new alkaline protease, according to claim 2, in which a medium containing 1 percent polypeptone and 1 percent meat extract as a nitrogen source 10 percent soluble starch as a carbon source, and 0.3 percent sodium chloride as an inorganic salt is employed.
- 4. A process for the production of a new alkaline protease, according to claim 2, in which a medium containing fishmeal as a nitrogen source, glucose-maltose syrup as a carbon source, and 0.1 percent K2HPO4, 0.3 percent sodium chloride and 0.05 percent magnesium sulfate as inorganic salts is employed.
- 5. A process for the production of a new alkaline protease, according to claim 2, in which a medium containing 2.0 percent polypeptone and 2.0 percent meat extract as a nitrogen source, 20 percent glucose-maltose syrup as a carbon source, and 0.3 percent sodium chloride as an inorganic salt is employed.
- 6. A process for the production of a new alkaline protease, according to claim 2, in which a purification comprises the steps of fractionally precipitating the filtrate of the culture broth with ammonium sulfate at pH 8.5, collecting the precipitate by centrifugation or by filtration, adjusting the pH to 10.0, dissolving said precipitate in the minimum required amount of distilled water, adding to the enzyme solution 1/10 by volume of Palitzsch borate buffer solution (pH 8.2), and readjusting said enzyme solution to between pH 8.2 and 9.0 by adding an acetic acid solution, and finally separating the enzyme produced in crystal form.
- 7. A process for the production of a new alkaline protease, according to claim 2, in which a purificatioN comprises the steps of precipitating the filtrate of the culture broth by adding acetone, dissolving the precipitate in the minimum required amount of distilled water, fractionally precipitating with ammonium sulfate, collecting the precipitate by centrifugation or filtration, dissolving said precipitate in the minimum required amount of distilled water at pH 9.0, readjusting the solution to between pH 8.2 and 8.5 with Paliztsch borate buffer (pH 8.2) or acetic acid solution, and finally separating the enzyme produced in crystal form.
- 8. A process for the production of a new alkaline protease, according to claim 2, which comprises steps of adjusting the pH of the filtrate of the culture broth to 8.2 with Paliztsch borate buffer or acetic acid solution, and separating therefrom the enzyme in crystal forms.
- 9. A process for the production of a new alkaline protease, according to claim 2, in which a purification comprises the steps of fractionally precipitating the filtrate of the culture broth with ammonium sulfate, collecting the precipitate by centrifugation or filtration, adjusting the pH to 9.0, dissolving it in the minimum required amount of distilled water, and purifying on a Sephadex column.
- 10. A process for the production of a new alkaline protease, according to claim 2, in which a purification comprises the steps of precipitation the filtrate of the culture broth with a solvent selected from the group consisting of acetone, methanol and ethanol, adjusting the precipitate to pH 9.0, dissolving it in distilled water, again precipitating it with the above solvent, and separating the pure enzyme crystals.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7108468 | 1968-10-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3622458A true US3622458A (en) | 1971-11-23 |
Family
ID=13450290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US861911A Expired - Lifetime US3622458A (en) | 1968-10-02 | 1969-09-29 | Production of a new protease |
Country Status (1)
Country | Link |
---|---|
US (1) | US3622458A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3871963A (en) * | 1972-03-18 | 1975-03-18 | Ajinomoto Kk | Microbial protease and preparation thereof |
US4002572A (en) * | 1974-11-19 | 1977-01-11 | Gist-Brocades N.V. | Alkaline protease produced by a bacillus |
WO1990004022A1 (en) * | 1988-10-11 | 1990-04-19 | Basf Aktiengesellschaft | Proteolytic alkaline enzyme, production and use thereof |
EP0571014A1 (en) * | 1992-05-18 | 1993-11-24 | Solvay Enzymes, Inc. | Alkaline proteases, bacteria producing them, process for the production of these alkaline proteases, uses of these alkaline proteases and detergent compositions containing them |
US5296367A (en) * | 1991-01-17 | 1994-03-22 | Kao Corporation | Alkaline proteinase isolated from bacillus sp. |
US5358865A (en) * | 1990-10-12 | 1994-10-25 | Novo Nordisk A/S | Alkaline protease from Bacillus J 20 |
US6207437B1 (en) * | 1996-03-11 | 2001-03-27 | Genencor International, Inc. | Crystalline protease and method for producing same |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3031380A (en) * | 1959-11-16 | 1962-04-24 | Pacific Lab Inc | Process for enzyme production |
-
1969
- 1969-09-29 US US861911A patent/US3622458A/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3031380A (en) * | 1959-11-16 | 1962-04-24 | Pacific Lab Inc | Process for enzyme production |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3871963A (en) * | 1972-03-18 | 1975-03-18 | Ajinomoto Kk | Microbial protease and preparation thereof |
US4002572A (en) * | 1974-11-19 | 1977-01-11 | Gist-Brocades N.V. | Alkaline protease produced by a bacillus |
USRE30602E (en) * | 1974-11-19 | 1981-05-05 | Gist-Brocades N.V. | Alkaline protease produced by a bacillus |
WO1990004022A1 (en) * | 1988-10-11 | 1990-04-19 | Basf Aktiengesellschaft | Proteolytic alkaline enzyme, production and use thereof |
US5358865A (en) * | 1990-10-12 | 1994-10-25 | Novo Nordisk A/S | Alkaline protease from Bacillus J 20 |
US5296367A (en) * | 1991-01-17 | 1994-03-22 | Kao Corporation | Alkaline proteinase isolated from bacillus sp. |
US5344770A (en) * | 1991-01-17 | 1994-09-06 | Kao Corporation | Bacillus SP. ferm BP-3376 and a method for its use to produce an alkaline proteinase K-16 |
EP0571014A1 (en) * | 1992-05-18 | 1993-11-24 | Solvay Enzymes, Inc. | Alkaline proteases, bacteria producing them, process for the production of these alkaline proteases, uses of these alkaline proteases and detergent compositions containing them |
US5385837A (en) * | 1992-05-18 | 1995-01-31 | Solvay Enzymes, Inc. | Alkaline proteases derived from Bacillus proteolyticus |
US5518917A (en) * | 1992-05-18 | 1996-05-21 | Solvay Enzymes, Inc. | Bacillus proteolyticus species which produce an alkaline protease |
US5565348A (en) * | 1992-05-18 | 1996-10-15 | Solvay Enzymes, Inc. | Alkaline protease from Bacillus proteolyticus species |
US6207437B1 (en) * | 1996-03-11 | 2001-03-27 | Genencor International, Inc. | Crystalline protease and method for producing same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Morihara et al. | Multiple proteolytic enzymes of Streptomyces fradiae production, isolation, and preliminary characterization | |
Ebeling et al. | Proteinase K from Tritirachium album limber | |
Morihara | Production of elastase and proteinase by Pseudomonas aeruginosa | |
US3623957A (en) | Preparation of microbial alkaline protease by fermentation with bacillus subtilis, variety licheniformis | |
US5275944A (en) | Thermostable purified endoglucanas from acidothermus cellulolyticus ATCC 43068 | |
US5296367A (en) | Alkaline proteinase isolated from bacillus sp. | |
EP0496361B1 (en) | Detergent composition | |
US3827938A (en) | Enzyme products | |
US3622458A (en) | Production of a new protease | |
US3871963A (en) | Microbial protease and preparation thereof | |
WO1988003948A1 (en) | Low-temperature active akaline protease from paecilomyces marquandii and its preparation | |
US4429044A (en) | Preparation of an alkaline protease from flavobacterium arborescens | |
US5192677A (en) | Alkali and heat stable protease from thermomonospora fusca | |
US3838009A (en) | Process for producing detergent resisting alkaline protease | |
WO1996025489A1 (en) | Psychrophilic protease and psychrophilic bacteria | |
US3684658A (en) | Enzymes and process for their preparation | |
US3576719A (en) | Alkaline proteinase | |
JPH06506354A (en) | Novel protease | |
US4014860A (en) | Plasminostreptin (enzyme inhibitor) and method for producing it from streptomyces | |
US3804718A (en) | Method of producing beta-amylase by bacterial fermentation | |
US3855065A (en) | Production of streptokinase | |
US3755081A (en) | Process for preparing l-serine | |
US3592737A (en) | Purification and fractionation of protease and amylase activities in enzyme mixture | |
US4062730A (en) | Procedure for producing enzymes | |
EP0839187B1 (en) | Proteolytic enzymes derived from amycolata |